Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological products, announced ...
© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback